CD274 and breast cancer: They were both found able to inhibit cell viability of about 30–40% at a concentration of 200 nM (see Fig. 2), thus indicating that the antitumor effect of PD-L1–1 was exerted not only on mammary cancer cells but also on different types of tumor cells.